|
1
|
Zou S, Li J, Zhou H, Frech C, Jiang X, Chu
JS, Zhao X, Li Y, Li Q, Wang H, et al: Mutational landscape of
intrahepatic cholangiocarcinoma. Nat Commun. 5:56962014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ali SM, Clark CJ, Mounajjed T, Wu TT,
Harmsen WS, Reid-Lombardo KM, Truty MJ, Kendrick ML, Farnell MB,
Nagorney DM, et al: Model to predict survival after surgical
resection of intrahepatic cholangiocarcinoma: the Mayo Clinic
experience. HPB (Oxford). 7:244–250. 2014.
|
|
3
|
Montrose DC, Nakanishi M, Murphy RC,
Zarini S, McAleer JP, Vella AT and Rosenberg DW: The role of PGE in
intestinal inflammation and tumorigenesis. Prostaglandins Other
Lipid Mediat. 116–117C:26–36. 2014.
|
|
4
|
Bai XM, Zhang W, Liu NB, Jiang H, Lou KX,
Peng T, Ma J, Zhang L, Zhang H and Leng J: Focal adhesion kinase:
Important to prostaglandin E2-mediated adhesion,
migration and invasion in hepatocellular carcinoma cells. Oncol
Rep. 21:129–136. 2009.
|
|
5
|
Bai XM, Jiang H, Ding JX, Peng T, Ma J,
Wang YH, Zhang L, Zhang H and Leng J: Prostaglandin E2
upregulates survivin expression via the EP1 receptor in
hepatocellular carcinoma cells. Life Sci. 86:214–223. 2010.
View Article : Google Scholar
|
|
6
|
Zhang M, Zhang H, Cheng S, Zhang D, Xu Y,
Bai X, Xia S, Zhang L, Ma J, Du M, et al: Prostaglandin E2
accelerates invasion by upregulating Snail in hepatocellular
carcinoma cells. Tumour Biol. 35:7135–7145. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng SY, Zhang H, Zhang M, Xia SK, Bai
XM, Zhang L, Ma J, Rong R, Wang YP, Du MZ, et al: Prostaglandin
E2 receptor EP2 mediates Snail expression in
hepatocellular carcinoma cells. Oncol Rep. 31:2099–2106.
2014.PubMed/NCBI
|
|
8
|
Zhang H, Cheng S, Zhang M, Ma X, Zhang L,
Wang Y, Rong R, Ma J, Xia S, Du M, et al: Prostaglandin
E2 promotes hepatocellular carcinoma cell invasion
through upregulation of YB-1 protein expression. Int J Oncol.
44:769–780. 2014.PubMed/NCBI
|
|
9
|
Xia S, Ma J, Bai X, Zhang H, Cheng S,
Zhang M, Zhang L, Du M, Wang Y, Li H, et al: Prostaglandin
E2 promotes the cell growth and invasive ability of
hepatocellular carcinoma cells by upregulating c-Myc expression via
EP4 receptor and the PKA signaling pathway. Oncol Rep.
32:1521–1530. 2014.PubMed/NCBI
|
|
10
|
Bai X, Wang J, Guo Y, Pan J, Yang Q, Zhang
M, Li H, Zhang L, Ma J, Shi F, et al: Prostaglandin E2 stimulates
β1-integrin expression in hepatocellular carcinoma through the EP1
receptor/PKC/NF-κB pathway. Sci Rep. 4:65382014. View Article : Google Scholar
|
|
11
|
Sun B, Rong R, Jiang H, Zhang H, Wang Y,
Bai X, Zhang M, Ma J, Xia S, Shu W, et al: Prostaglandin
E2 receptor EP1 phosphorylate CREB and mediates MMP2
expression in human cholangiocarcinoma cells. Mol Cell Biochem.
378:195–203. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma J, Chen M, Xia SK, Shu W, Guo Y, Wang
YH, Xu Y, Bai XM, Zhang L, Zhang H, et al: Prostaglandin
E2 promotes liver cancer cell growth by the upregulation
of FUSE-binding protein 1 expression. Int J Oncol. 42:1093–1104.
2013.PubMed/NCBI
|
|
13
|
Cao J, Yang X, Li WT, Zhao CL and Lv SJ:
Silencing of COX-2 by RNAi modulates epithelial-mesenchymal
transition in breast cancer cells partially dependent on the PGE2
cascade. Asian Pac J Cancer Prev. 15:9967–9972. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dufour M, Faes S, Dormond-Meuwly A,
Demartines N and Dormond O: PGE2-induced colon cancer growth is
mediated by mTORC1. Biochem Biophys Res Commun. 451:587–591. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiu X, Cheng JC, Chang HM and Leung PC:
COX2 and PGE2 mediate EGF-induced E-cadherin-independent human
ovarian cancer cell invasion. Endocr Relat Cancer. 21:533–543.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu T: Cyclooxygenase-2 and prostaglandin
signaling in cholangiocarcinoma. Biochim Biophys Acta.
1755:135–150. 2005.PubMed/NCBI
|
|
17
|
Kim SO, Dozier BL, Kerry JA and Duffy DM:
EP3 receptor isoforms are differentially expressed in
subpopulations of primate granulosa cells and couple to unique
G-proteins. Reproduction. 146:625–635. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lemieux E, Cagnol S, Beaudry K, Carrier J
and Rivard N: Oncogenic KRAS signalling promotes the Wnt/β-catenin
pathway through LRP6 in colorectal cancer. Oncogene. Dec 15–2014,
http://dx.doi.org/10.1038/onc.2014.416.
View Article : Google Scholar
|
|
19
|
Rath G, Jawanjal P, Salhan S, Nalliah M
and Dhawan I: Clinical significance of inactivated glycogen
synthase kinase 3beta in HPV-associated cervical cancer:
Relationship with Wnt/beta-catenin pathway activation. Am J Reprod
Immunol. 73:460–478. 2015. View Article : Google Scholar
|
|
20
|
Vatansever HS, Gumus B, Aydogdu O,
Sivrikoz ON, Türköz-Uluer E, Kivanç M, Ateşçi YZ and Bugdayci H:
The role of stem/progenitor cells and Wnt/β-catenin signaling
pathway in the patients with prostate cancer. Minerva Urol Nefrol.
66:249–255. 2014.PubMed/NCBI
|
|
21
|
Thompson MD and Monga SP: WNT/beta-catenin
signaling in liver health and disease. Hepatology. 45:1298–1305.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li P, Cao Y, Li Y, Zhou L, Liu X and Geng
M: Expression of Wnt-5a and β-catenin in primary hepatocellular
carcinoma. Int J Clin Exp Pathol. 7:3190–3195. 2014.
|
|
23
|
Ao R, Zhang DR, Du YQ and Wang Y:
Expression and significance of Pin1, β-catenin and cyclin D1 in
hepatocellular carcinoma. Mol Med Rep. 10:1893–1898.
2014.PubMed/NCBI
|
|
24
|
Gedaly R, Galuppo R, Daily MF, Shah M,
Maynard E, Chen C, Zhang X, Esser KA, Cohen DA, Evers BM, et al:
Targeting the Wnt/β-catenin signaling pathway in liver cancer stem
cells and hepatocellular carcinoma cell lines with FH535. PLoS One.
9:e992722014. View Article : Google Scholar
|
|
25
|
Tokumoto N, Ikeda S, Ishizaki Y, Kurihara
T, Ozaki S, Iseki M, Shimizu Y, Itamoto T, Arihiro K, Okajima M, et
al: Immunohistochemical and mutational analyses of Wnt signaling
components and target genes in intrahepatic cholangiocarcinomas.
Int J Oncol. 27:973–980. 2005.PubMed/NCBI
|
|
26
|
Lim K, Han C, Xu L, Isse K, Demetris AJ
and Wu T: Cyclooxygenase-2-derived prostaglandin E2
activates beta-catenin in human cholangiocarcinoma cells: Evidence
for inhibition of these signaling pathways by omega 3
polyunsaturated fatty acids. Cancer Res. 68:553–560. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee KB, Ye S, Park MH, Park BH, Lee JS and
Kim SM: p63-Mediated activation of the β-catenin/c-Myc signaling
pathway stimulates esophageal squamous carcinoma cell invasion and
metastasis. Cancer Lett. 353:124–132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang H, Zhang G, Zhang H, Zhang F, Zhou B,
Ning F, Wang HS, Cai SH and Du J: Acquisition of
epithelial-mesenchymal transition phenotype and cancer stem
cell-like properties in cisplatin-resistant lung cancer cells
through AKT/β-catenin/Snail signaling pathway. Eur J Pharmacol.
723:156–166. 2014. View Article : Google Scholar
|
|
29
|
Ripple MJ, Parker Struckhoff A,
Trillo-Tinoco J, Li L, Margolin DA, McGoey R and Del Valle L:
Activation of c-Myc and Cyclin D1 by JCV T-Antigen and β-catenin in
colon cancer. PLoS One. 9:e1062572014. View Article : Google Scholar
|
|
30
|
Manoukian AS and Woodgett JR: Role of
glycogen synthase kinase-3 in cancer: Regulation by Wnts and other
signaling pathways. Adv Cancer Res. 84:203–229. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Castellone MD, Teramoto H, Williams BO,
Druey KM and Gutkind JS: Prostaglandin E2 promotes colon
cancer cell growth through a Gs-axin-beta-catenin signaling axis.
Science. 310:1504–1510. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng WH, Kar S and Quirion R:
Insulin-like growth factor-1-induced phosphorylation of the
forkhead family transcription factor FKHRL1 is mediated by Akt
kinase in PC12 cells. J Biol Chem. 275:39152–39158. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han C, Michalopoulos GK and Wu T:
Prostaglandin E2 receptor EP1 transactivates EGFR/MET
receptor tyrosine kinases and enhances invasiveness in human
hepatocellular carcinoma cells. J Cell Physiol. 207:261–270. 2006.
View Article : Google Scholar
|
|
34
|
Zhang L, Jiang L, Sun Q, Peng T, Lou K,
Liu N and Leng J: Prostaglandin E2 enhances mitogen-activated
protein kinase/Erk pathway in human cholangiocarcinoma cells:
Involvement of EP1 receptor, calcium and EGF receptors signaling.
Mol Cell Biochem. 305:19–26. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bos CL, Richel DJ, Ritsema T,
Peppelenbosch MP and Versteeg HH: Prostanoids and prostanoid
receptors in signal transduction. Int J Biochem Cell Biol.
36:1187–1205. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Orie NN and Clapp LH: Role of prostanoid
IP and EP receptors in mediating vasorelaxant responses to PGI2
analogues in rat tail artery: Evidence for Gi/o modulation via EP3
receptors. Eur J Pharmacol. 654:258–265. 2011. View Article : Google Scholar
|
|
37
|
De Langhe SP and Reynolds SD: Wnt
signaling in lung organogenesis. Organogenesis. 4:100–108. 2008.
View Article : Google Scholar
|
|
38
|
Wodarz A and Nusse R: Mechanisms of Wnt
signaling in development. Annu Rev Cell Dev Biol. 14:59–88. 1998.
View Article : Google Scholar
|
|
39
|
Cui L, Jia X, Zhou Q, Zhai X, Zhou Y and
Zhu H: Curcumin affects β-catenin pathway in hepatic stellate cell
in vitro and in vivo. J Pharm Pharmacol. 66:1615–1622. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ge WS, Wang YJ, Wu JX, Fan JG, Chen YW and
Zhu L: β-catenin is overexpressed in hepatic fibrosis and blockage
of Wnt/β-catenin signaling inhibits hepatic stellate cell
activation. Mol Med Rep. 9:2145–2151. 2014.PubMed/NCBI
|
|
41
|
Pulkkinen K, Murugan S and Vainio S: Wnt
signaling in kidney development and disease. Organogenesis.
4:55–59. 2008. View Article : Google Scholar
|
|
42
|
Nelson PJ, von Toerne C and Gröne HJ:
Wnt-signaling pathways in progressive renal fibrosis. Expert Opin
Ther Targets. 15:1073–1083. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wuebken A and Schmidt-Ott KM:
WNT/β-catenin signaling in polycystic kidney disease. Kidney Int.
80:135–138. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Terada Y, Tanaka H, Okado T, Shimamura H,
Inoshita S, Kuwahara M and Sasaki S: Expression and function of the
developmental gene Wnt-4 during experimental acute renal failure in
rats. J Am Soc Nephrol. 14:1223–1233. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hsu RJ, Ho JY, Cha TL, Yu DS, Wu CL, Huang
WP, Chu P, Chen YH, Chen JT and Yu CP: WNT10A plays an oncogenic
role in renal cell carcinoma by activating WNT/β-catenin pathway.
PLoS One. 7:e476492012. View Article : Google Scholar
|
|
46
|
Ueno K, Hirata H, Majid S, Tabatabai ZL,
Hinoda Y and Dahiya R: IGFBP-4 activates the Wnt/beta-catenin
signaling pathway and induces M-CAM expression in human renal cell
carcinoma. Int J Cancer. 129:2360–2369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lu D, Han C and Wu T: Microsomal
prostaglandin E synthase-1 promotes hepatocarcinogenesis through
activation of a novel EGR1/β-catenin signaling axis. Oncogene.
31:842–857. 2012. View Article : Google Scholar
|
|
48
|
Llovet JM and Bruix J: Molecular targeted
therapies in hepatocellular carcinoma. Hepatology. 48:1312–1327.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu C, Li Y, Semenov M, Han C, Baeg GH,
Tan Y, Zhang Z, Lin X and He X: Control of beta-catenin
phosphorylation/degradation by a dual-kinase mechanism. Cell.
108:837–847. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hoppler S and Kavanagh CL: Wnt signalling:
Variety at the core. J Cell Sci. 120:385–393. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Han C and Wu T: Cyclooxygenase-2-derived
prostaglandin E2 promotes human cholangiocarcinoma cell
growth and invasion through EP1 receptor-mediated
activation of the epidermal growth factor receptor and Akt. J Biol
Chem. 280:24053–24063. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Glaysher S, Bolton LM, Johnson P, Atkey N,
Dyson M, Torrance C and Cree IA: Targeting EGFR and PI3K pathways
in ovarian cancer. Br J Cancer. 109:1786–1794. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Aasrum M, Odegård J, Sandnes D and
Christoffersen T: The involvement of the docking protein Gab1 in
mitogenic signalling induced by EGF and HGF in rat hepatocytes.
Biochim Biophys Acta. 1833:3286–3294. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mouradian M, Kikawa KD, Johnson ED, Beck
KL and Pardini RS: Key roles for GRB2-associated-binding protein 1,
phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2
and transforming growth factor alpha in linoleic acid-induced
upregulation of lung and breast cancer cell growth. Prostaglandins
Leukot Essent Fatty Acids. 90:105–115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cardoso AP, Pinto ML, Pinto AT, Oliveira
MI, Pinto MT, Gonçalves R, Relvas JB, Figueiredo C, Seruca R,
Mantovani A, et al: Macrophages stimulate gastric and colorectal
cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt
phosphorylation and smallGTPase activity. Oncogene. 33:2123–2133.
2014. View Article : Google Scholar
|
